Correlation Between Preoperative Refraction and Anterior Segment Parameters With ICL Vault
Launched by KASR EL AINI HOSPITAL · Jan 1, 2023
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This clinical trial is studying how certain factors before surgery can affect the outcome of a specific eye procedure called ICL implantation, which is used to correct vision problems like high myopia (nearsightedness) and myopic astigmatism. Researchers want to understand how things like age, gender, and measurements of the eye relate to the success of the surgery in achieving the right positioning of the ICL, which is important for clear vision after the procedure.
To be eligible for this study, participants should be between 21 and 45 years old, have high myopia or myopic astigmatism, and have stable vision for the past year. They should also have a specific eye measurement called anterior chamber depth, and they should not be suitable candidates for another type of eye surgery called LASIK. Those who join the study will undergo some pre-surgery eye tests and then have the ICL surgery. After the procedure, they will return for follow-up visits to check how well the surgery worked and how their vision has improved. It's important to note that individuals with certain eye conditions or systemic diseases may not be eligible to participate.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age:21 - 45 years old.
- • High Myopia or Myopic astigmatism.
- • Patients with stable preoperative refraction for the previous 12 months.
- • Aqueous depth (ACD internal) = 2.8 mm or greater from the endothelial side using pentacam.
- • Patients who are not fit for LASIK.
- • No previous intraocular surgeries.
- Exclusion Criteria:
- • Patients with endothelial cell count \< 2800 cells /mm2
- • Patients with corneal opacities
- • Patients with preoperative glaucoma, cataract, and retinal disease.
- • Patients with any systemic diseases especially collagen diseases.
About Kasr El Aini Hospital
Kasr El Aini Hospital, a prestigious medical institution affiliated with Cairo University, is dedicated to advancing healthcare through innovative clinical research. With a commitment to excellence, the hospital serves as a leading sponsor of clinical trials, leveraging its state-of-the-art facilities and a multidisciplinary team of healthcare professionals. The institution focuses on a diverse range of therapeutic areas, aiming to improve patient outcomes and contribute to the global medical community. By fostering collaboration and adhering to the highest ethical standards, Kasr El Aini Hospital plays a pivotal role in the development of new treatments and therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Trial Officials
Adel M Fathy, Prof. DR
Study Director
Faculty of medicine Kasr El Aini
Ramy R Fikry, Ass prof
Study Director
Faculty of medicine Kasr El Aini
Mohamed A Anis, Ass Prof
Study Director
Faculty of medicine Kasr El Aini
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials